Fig. 4From: Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)Numbers of patients with change in grade of chemotherapy-induced peripheral neuropathy according to the Common Terminology Criteria for Adverse Events over 12Â weeks (full analysis set). Data are presented as percentage of patients. CIPN, chemotherapy-induced peripheral neuropathyBack to article page